These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34977338)

  • 1. Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity.
    Chai D; Qiu D; Shi X; Ding J; Jiang N; Zhang Z; Wang J; Yang J; Xiao P; Wang G; Zheng J
    Mol Ther Oncolytics; 2022 Mar; 24():1-13. PubMed ID: 34977338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-immunization with L-Myc enhances CD8
    Chai D; Zhang Z; Jiang N; Ding J; Qiu D; Shi SY; Wang G; Fang L; Li H; Tian H; Yang J; Zhang Q; Zheng J
    Cancer Sci; 2021 Sep; 112(9):3469-3483. PubMed ID: 34157192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8
    Chai D; Shan H; Wang G; Zhang Q; Li H; Fang L; Song J; Liu N; Zhang Q; Yao H; Zheng J
    Mol Cancer Ther; 2019 Feb; 18(2):323-334. PubMed ID: 30401695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-immunizing with PD-L1 induces CD8
    Guo S; Xiao P; Li B; Wang W; Wang S; Lv T; Xu X; Chen C; Huang L; Li Z; Tang L; Peng L; Wang H
    Int Immunopharmacol; 2020 Jul; 84():106516. PubMed ID: 32334387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8
    Shi X; Ding J; Zheng Y; Wang J; Sobhani N; Neeli P; Wang G; Zheng J; Chai D
    iScience; 2023 Mar; 26(3):106143. PubMed ID: 36879804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus vaccine therapy with CD137L promotes CD8
    Ding J; Jiang N; Zheng Y; Wang J; Fang L; Li H; Yang J; Hu A; Xiao P; Zhang Q; Chai D; Zheng J; Wang G
    Pharmacol Res; 2022 Jan; 175():106034. PubMed ID: 34915126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.
    Jiang N; Zheng Y; Ding J; Wang J; Zhu F; Wang M; Sobhani N; Neeli P; Wang G; Li H; Zheng J; Chai D
    NPJ Vaccines; 2023 Aug; 8(1):109. PubMed ID: 37542081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors.
    Ding J; Zheng Y; Zhu F; Wang M; Fang L; Li H; Tian H; Liu Y; Wang G; Zheng J; Chai D
    Int Immunopharmacol; 2023 Oct; 123():110722. PubMed ID: 37573687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8
    Zheng Y; Lu Z; Ding J; Jiang N; Wang J; Yang J; Song J; Chen H; Fang L; Li H; Tian H; Wang G; Zheng J; Chai D
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-immunizing with HMGB1 enhances anti-tumor immunity of B7H3 vaccine in renal carcinoma.
    Sun H; Li J; Hu W; Yan Y; Guo Z; Zhang Z; Chen Y; Yao X; Teng L; Wang X; Li L; Chai D; Zheng J; Wang G
    Mol Immunol; 2021 Nov; 139():184-192. PubMed ID: 34560414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.
    Rosalia RA; Cruz LJ; van Duikeren S; Tromp AT; Silva AL; Jiskoot W; de Gruijl T; Löwik C; Oostendorp J; van der Burg SH; Ossendorp F
    Biomaterials; 2015 Feb; 40():88-97. PubMed ID: 25465442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant for H9N2 vaccine to improve immune responses in chickens compared to Alum and oil-based adjuvants.
    Gu P; Wusiman A; Zhang Y; Cai G; Xu S; Zhu S; Liu Z; Hu Y; Liu J; Wang D
    Vet Microbiol; 2020 Dec; 251():108894. PubMed ID: 33096470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of biodegradable nanoparticles as antigen delivery system.
    Petrizzo A; Conte C; Tagliamonte M; Napolitano M; Bifulco K; Carriero V; De Stradis A; Tornesello ML; Buonaguro FM; Quaglia F; Buonaguro L
    J Exp Clin Cancer Res; 2015 Oct; 34():114. PubMed ID: 26444005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.
    Song C; Noh YW; Lim YT
    Int J Nanomedicine; 2016; 11():3753-64. PubMed ID: 27540289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
    Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
    Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing Dendritic Cells for Poly (D,L-lactide-
    Koerner J; Horvath D; Groettrup M
    Front Immunol; 2019; 10():707. PubMed ID: 31024545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
    Cruz LJ; Rosalia RA; Kleinovink JW; Rueda F; Löwik CW; Ossendorp F
    J Control Release; 2014 Oct; 192():209-18. PubMed ID: 25068703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.